HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.

Abstract
Flavangenol, one of several pine bark extract products, is expected to prevent metabolic diseases with its potent antioxidant effect, its anti-obesity effect and its improvement of insulin sensitivity. In this study, targeting the liver as one of the organs that plays an important role in energy metabolism, Flavangenol was investigated for its effect on non-alcoholic fatty liver disease (NAFLD), its action mechanism and its active ingredients, using in vivo and in vitro experiment systems. Flavangenol suppressed intrahepatic fat accumulation in Western diet-loaded Tsumura Suzuki Obese Diabetes (TSOD) mice, which develop various metabolic diseases. In addition, Flavangenol significantly increased the mRNA expression levels of fatty acid oxidative enzymes (peroxisomal proliferator-activated receptor α, acyl-CoA oxidase, carnitine palmitoyltransferase). In order to investigate the direct effect of Flavangenol on the liver, an in vitro fatty liver model prepared by adding a free fatty acid to human liver cancer cells (HepG2 cells) was used. In this model, Flavangenol significantly suppressed intracellular fat accumulation. Procyanidin B1, one of the major components of Flavangenol, also suppressed fat accumulation and induced mRNA expression of the fatty acid oxidative enzymes. As mentioned above, Flavangenol showed a significant suppressive effect in the NAFLD model, and it was suggested that the molecular mechanism is induction of fatty acid oxidation, with the effect mainly attributed to procyanidin B1.
AuthorsTsutomu Shimada, Daisuke Tokuhara, Masahito Tsubata, Tomoyasu Kamiya, Mayu Kamiya-Sameshima, Rika Nagamine, Kinya Takagaki, Yoshimichi Sai, Ken-Ichi Miyamoto, Masaki Aburada
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 677 Issue 1-3 Pg. 147-53 (Feb 29 2012) ISSN: 1879-0712 [Electronic] Netherlands
PMID22227333 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Biflavonoids
  • Fatty Acids
  • Plant Extracts
  • Proanthocyanidins
  • RNA, Messenger
  • flavangenol
  • procyanidin B1
  • Catechin
Topics
  • Animals
  • Biflavonoids (chemistry, pharmacology)
  • Catechin (pharmacology)
  • Diabetes Mellitus (metabolism)
  • Disease Models, Animal
  • Fatty Acids (metabolism)
  • Fatty Liver (diagnostic imaging, metabolism, pathology, physiopathology)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism (drug effects)
  • Liver (drug effects, metabolism, pathology, physiopathology)
  • Liver Function Tests
  • Male
  • Mice
  • Non-alcoholic Fatty Liver Disease
  • Obesity (metabolism)
  • Oxidation-Reduction (drug effects)
  • Pinus (chemistry)
  • Plant Bark (chemistry)
  • Plant Extracts (chemistry, pharmacology)
  • Proanthocyanidins (chemistry, pharmacology)
  • RNA, Messenger (genetics, metabolism)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: